Peptide-major histocompatibility complex class II–T cell receptor complex (Peptide–MHC class II–TCR complex)

The **peptide-major histocompatibility complex class II–T cell receptor complex** (Peptide–MHC class II–TCR complex) is a multiprotein assembly formed when a fragment of antigenic peptide is displayed on the surface of an antigen-presenting cell (APC) by a major histocompatibility complex class II (MHC-II) molecule and specifically recognized by the antigen receptor of CD4+ T cells (T cell receptor, TCR)[2][4][5][6]. The interaction is central to adaptive immune responses, as the TCR engages both the presented peptide and polymorphic regions of the MHC-II molecule[3][5]. Recognition leads to T cell activation, proliferation, and cytokine production, enabling immune surveillance and pathogen clearance[5][7]. Structural studies reveal that the TCR–peptide–MHC II complex exhibits a typical docking geometry in which hypervariable regions of the TCR interact with both the peptide and MHCII α- and β-helices, providing the molecular basis for epitope specificity, alloreactivity, and the potential for both protective and pathogenic immune responses[2][5][6][7]. The complex is a key target for immunotherapies, including engineered T cells in cancer and autoimmune disorders, and its specificity and cross-reactivity are critical for both efficacy and safety[7].

Other names

pMHC class II–TCR complexPeptide–MHCII–TCR complexTCR–pMHCII complexPeptide–MHC class II–T-cell receptor complexT-cell receptor–peptide MHC class II complex

Immune modulation via presentation of peptide antigens and direct TCR engagement Activation or suppression of T cell responses upon complex formation Therapeutic TCRs can bind specific pMHC II complexes to target diseased cells for destruction